Metabolic dysfunction and steatotic liver disease

163
Total downloads
905
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Accepted on 27 Mar 2025

Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition

Roger Bentanachs
Lluïsa Miró
Patricia Ramírez-Carrasco
Rosa M Sánchez
Manuel Bernabeu Lorenzo
Concepció Amat
Marta Alegret Jorda
Anna Pérez-Bosque
Núria Roglans
Joan Carles Laguna

doi 10.3389/fphar.2025.1547749

ORIGINAL RESEARCH

Published on 05 Mar 2025

Reversed role of CD36 deficiency in high-fat diet or methionine/choline-deficient diet-induced hepatic steatosis and steatohepatitis

Wenya Zhu
Jialing Ma
Tingting Zhang
Mengmeng Zhu
Yajun Duan
Xiaoxiao Yang
Yuanli Chen

doi 10.3389/fphar.2025.1522177

352 views

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Gastrointestinal and Hepatic Pharmacology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

905Topic views
352Article views
163Article downloads